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Borrelia burgdorferi Harbors a Transport System Essential for Purine
Salvage and Mammalian Infection
Sunny Jain,a Selina Sutchu,a Patricia A. Rosa,b Rebecca Byram,b and Mollie W. Jewetta
Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida, USA,a and Laboratory of Zoonotic Pathogens, Rocky Mountain
Labs, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USAb

Borrelia burgdorferi is the tick-borne bacterium that causes the multistage inflammatory disease Lyme disease. B. burgdorferi
has a reduced genome and lacks the enzymes required for de novo synthesis of purines for synthesis of RNA and DNA. Therefore, this obligate pathogen is dependent upon the tick vector and mammalian host environments for salvage of purine bases for
nucleic acid biosynthesis. This pathway is vital for B. burgdorferi survival throughout its infectious cycle, as key enzymes in the
purine salvage pathway are essential for the ability of the spirochete to infect mice and critical for spirochete replication in the
tick. The transport of preformed purines into the spirochete is the first step in the purine salvage pathway and may represent a
novel therapeutic target and/or means to deliver antispirochete molecules to the pathogen. However, the transport systems critical for purine salvage by B. burgdorferi have yet to be identified. Herein, we demonstrate that the genes bbb22 and bbb23, present
on B. burgdorferi’s essential plasmid circular plasmid 26 (cp26), encode key purine transport proteins. BBB22 and/or BBB23 is
essential for hypoxanthine transport and contributes to the transport of adenine and guanine. Furthermore, B. burgdorferi lacking bbb22-23 was noninfectious in mice up to a dose of 1 ⴛ 107 spirochetes. Together, our data establish that bbb22-23 encode
purine permeases critical for B. burgdorferi mammalian infectivity, suggesting that this transport system may serve as a novel
antimicrobial target for the treatment of Lyme disease.

B

orrelia burgdorferi, the pathogenic spirochete that causes Lyme
disease, is an obligate parasite that cycles in nature between the
tick vector, Ixodes sp., and mammalian host, typically a small rodent. Transmission of B. burgdorferi to humans by tick bite, although not part of the zoonotic infectious cycle of the spirochete,
results in Lyme disease. Unlike many other bacterial pathogens, B.
burgdorferi is not known to harbor classic virulence factors, such
as toxins or secretion systems to deliver bacterial effector molecules (8, 13). Clinical manifestations associated with Lyme disease
are believed to result from the immune response to the spirochetal
infection (39). Therefore, genes encoding physiological functions
that allow for growth within the infected host are important virulence determinants (18, 19, 27), as survival is a critical component
of B. burgdorferi pathogenesis.
B. burgdorferi lacks the enzymes required for de novo synthesis
of purines and therefore relies absolutely upon salvage of purines
from its environment for nucleic acid biosynthesis (3, 19, 22, 26).
B. burgdorferi has evolved a novel purine salvage pathway that, in
addition to scavenge of purine bases, involves the salvage of deoxynucleotides from the host environment. Purine metabolism in
B. burgdorferi also utilizes interconversion of purine bases to deoxynucleosides by the deoxyribosyltransferase BB0426 and the catalysis of IMP to GMP and dIMP to dGMP by GuaA and GuaB,
respectively (22). This pathway is vital for B. burgdorferi survival
throughout its infectious cycle, as key enzymes in this purine salvage pathway are essential for the ability of the spirochete to infect
mice and critical for spirochete replication in the tick (18, 19). The
transport of preformed purines into the spirochete represents the
first step in the purine salvage pathway; however, the transport
systems critical for purine salvage by B. burgdorferi have yet to be
identified.
Circular plasmid 26 (cp26) is the only plasmid that is present in
all B. burgdorferi isolates examined to date and is not lost during in
vitro propagation. This plasmid carries genes essential for survival
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of the spirochete during both in vitro and in vivo growth (7, 17).
Cp26 harbors the essential gene resT, which encodes the telomere
resolvase required for replication of linear plasmids and the linear
chromosome (7), and the ospC gene, which is critical for mammalian infection (15, 34, 35, 38). Furthermore, cp26 carries the genes
encoding IMP dehydrogenase (GuaB) and GMP synthase (GuaA),
two key enzymes in the B. burgdorferi purine salvage pathway,
described above (19, 22, 24). In addition to genes involved in
peptide transport (oppAIV) (4), chitobiose transport (chbA, chbB,
and chbC) (36), and glucose transport (bbb29) (7), cp26 harbors
two adjacent genes, bbb22 and bbb23, both of which are hypothesized to encode putative purine permeases (7).
Herein we establish that the BBB22 and BBB23 proteins function to transport hypoxanthine, adenine, and guanine. Moreover,
our results demonstrate that this transport system is absolutely
required for survival of B. burgdorferi during mammalian infection.
MATERIALS AND METHODS
Bacterial clones and growth conditions. All low-passage-number B.
burgdorferi clones were derived from infectious clone A3-68⌬BBE02,
which lacks cp9, lp56, and the gene bbe02 on lp25 (28). B. burgdorferi was
grown in liquid Barbour-Stoenner-Kelly (BSK) II medium supplemented
with gelatin and 6% rabbit serum (2) and plated in solid BSK medium as
previously described (29, 30). All spirochete cultures were grown at 35°C
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TABLE 1 Primers and probes used in this study
Primer or probe

Designation

Sequence (5=–3=)

1
2
3
4
5
6
7
8
9
10
11
12
13
14

BBB22 ⫺ 500
BBB23 ⫹ 500
aadA-3= Xho1
flaB- 5= Xho1
BBB22-3= HindIII
BBB23-5= BamHI
BBB22F (17918) Sall 3=
BBB23R (20824) Sall 5=
BBB22-Fwd TaqMan
BBB22-Rev TaqMan
BBB23-Fwd TaqMan
BBB23-Rev TaqMan
BBB22 Probe
BBB23 Probe

CAGTTAAAGAGCTTACAAGCCC
AGGATACCTTGCAATATGATCC
CCGCTCGAGTTATTTGCCGACCTACCTTGG
CCGCTCGAGCTGTCGCCTCTTGTGGCTTC
CCCAAGCTTGACTCTTTTTTATGATTTATAATTTAGG
CGGGATCCTATTTTCAAACTTTACCTGACAGCG
ACGCGTCGACCCTAAATTATAAATCATAAAAAAGAGTC
ACGCGTCGACAATAATTATTAGGCTTTTAATTCTTTTTAAAGGCC
AAGAAATTATCGGTGGTATTACCACTTT
CAATTGGCATACCTGTGCTAGATAATAT
GCACTAGTTACCGCAACCTGTCT
CTCATTCCAGAAGCCAATGCT
AGCATGGCATACATAATAGCTGTTAATCCGGC
CTAATGGGACTTTATACCAATACGCCTT

and supplemented with 2.5% CO2. Kanamycin was used at 200 g/ml,
streptomycin at 50 g/ml, and gentamicin at 40 g/ml, when appropriate.
All cloning steps were carried out using Escherichia coli DH5␣. E. coli
cultures were grown in LB broth or on LB agar plates containing 50 g/ml
kanamycin, 300 g/ml spectinomycin, or 10 g/ml gentamicin.
Deletion of bbb22-23. A 3.8-kb DNA fragment encompassing the
BBB22 and BBB23 open reading frames (ORFs) along with 500-bp flanking regions from both sides was amplified from B. burgdorferi B31 clone
A3 genomic DNA using the Expand Long PCR system (Roche) and primers 1 and 2 (Table 1) and was cloned into the TOPO XL vector (Invitrogen), creating plasmid TOPO XL bbb22-23⫹500. The 2.8-kb DNA sequence containing the BBB22 and BBB23 ORFs was removed by inverse
PCR using the Expand Long PCR system (Roche) and primers 7 and 8,
generating linear p⌬bbb22-23 with SalI ends. A spectinomycin and streptomycin resistance cassette, flaBp-aadA (17) with XhoI ends, was amplified using Taq polymerase and primers 3 and 4. The flaBp-aadA product
was treated with XhoI and ligated with SalI- and DpnI-digested linear
p⌬bbb22-23, yielding the allelic-exchange plasmid p⌬bbb22-23-flaBpaadA. B. burgdorferi A3-68⌬BBE02 was transformed with 20 g of
p⌬bbb22-23-flaBp-aadA purified from E. coli as previously described (12,
14, 30). Streptomycin-resistant colonies were confirmed to be true transformants by PCR using primer pairs 1 and 2 and 5 and 6. Positive ⌬bbb2223-flaBp-aadA clones were screened with a panel of primers for the presence of all of the B. burgdorferi plasmids of the parent A3-68⌬BBE02 clone
(28), and a single clone was selected for further experiments.
Complementation of the ⌬bbb22-23 mutant. A DNA fragment encompassing the bbb22-23 genes and upstream putative promoter sequence was amplified from B31 A3 genomic DNA using Phusion enzyme
(Thermo Scientific) and primers 5 and 6 (Table 1), which introduced
BamHI and HindIII sites at the 5= and 3= ends, respectively. The BamHIand HindIII-digested PCR product was ligated into BamHI- and HindIIIcut B. burgdorferi shuttle vector pBSV2G (12). The plasmid structure and
sequence were confirmed by restriction digest and DNA sequence analysis. The ⌬bbb22-23 mutant was transformed with 20 g of pBSV2G
bbb22-23 or pBSV2G isolated from E. coli and positive transformants
selected as previously described (18). The clones that retained the B. burgdorferi plasmid content of the parent clone were selected for use in further
experiments.
In vitro growth analysis. Wild-type (A3-68⌬BBE02), ⌬bbb22-23/vector, and ⌬bbb22-23/bbb22-23⫹ spirochetes were inoculated in triplicate at
a density of 105 spirochetes/ml in 5 ml of BSK II medium. Spirochete
densities were determined every 24 h under dark-field microscopy using a
Petroff-Hausser chamber over the course of 96 h.
RNA isolation from in vitro-grown spirochetes. Wild-type (B31 A3)
spirochetes were grown in triplicate in 5 ml of BSK II medium (pH 7.5) at
35°C to a density of 2 ⫻ 108 spirochetes/ml. A total of 1 ⫻ 107 spirochetes
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were harvested from each culture and resuspended in 25 l of RNAlater
(Life Technologies) and stored at ⫺80°C until processing. Total RNA was
isolated using TRIzol reagent (Life Technologies) according to the manufacturer’s instructions. RNA was resuspended in 100 l of diethyl pyrocarbonate (DEPC)-treated distilled water (dH2O). RNA was treated with
TURBO DNase (Life Technologies) to remove any contaminating
genomic DNA. A total of 1 l of Riboguard (40 U/l) RNase inhibitor
(Epicentre) was added to all samples and RNA stored at ⫺80°C.
RNA isolation from infected mouse tissue. B. burgdorferi-infected
mouse hearts (see “Mouse infection experiments” below) were manually
macerated on ice using sterile scalpels and transferred to a 2-ml tube
containing lysing Matrix D (MP Biomedicals). A total of 1 ml of RNApro
solution (FastRNA Pro Green kit; MP Biomedicals) was added to each
sample on ice. Tissues were homogenized using a PowerGen highthroughput homogenizer (Fisher Scientific) following six cycles of beating
for 45 s and 2 min on ice. Samples were centrifuged at 15,300 ⫻ g for 5 min
at 4°C. The upper aqueous phase was transferred to new tubes and incubated for 5 min at room temperature. A total of 500 l of 1-bromo-3chloropropane (Sigma) and 45 l of 5 M sodium acetate were added to
each sample, and samples were incubated for an additional 5 min at room
temperature. Samples were centrifuged at 15,300 ⫻ g for 5 min at 4°C. The
upper aqueous phase was transferred to new tubes and RNA precipitated
with the addition of 500 l of absolute ethanol and 1 l of GlycoBlue (Life
Technologies). RNA was pelleted by centrifugation at 15,300 ⫻ g for 10
min at 4°C. RNA was then washed with 70% ethanol in DEPC-treated
H2O and resuspended in 100 l of DEPC-treated H2O. Finally, RNA was
treated with TURBO DNase (Life Technologies) to remove any contaminating genomic DNA. A total of 1 l of Riboguard (40 U/l) RNase
inhibitor (Epicentre) was added to all samples and RNA stored at ⫺80°C.
Gene expression analysis. cDNA was synthesized from all RNA samples using the qScript Flex cDNA synthesis kit (Quanta BioSciences) with
random hexamer primers according to the manufacturer’s instructions.
Parallel cDNA reactions were carried out in the absence of reverse transcriptase. Real-time quantitative PCRs (qPCRs) were prepared using 5 l
of cDNA and Perfecta qPCR Fast Mix (Quanta BioSciences). Using an
Applied Biosystems 7500 instrument, samples were assayed for the flaB
(19), bbb22, and bbb23 transcripts using primer pair 9 and 10 (Table 1),
primer pair 11 and 12, and probes 13 and 14, respectively. The flaB transcript was used as the endogenous reference to which the transcripts of the
target genes were normalized. The bbb22 and bbb23 primers were confirmed to be specific for their respective gene targets. The amounts of the
flaB, bbb22, and bbb23 transcripts were determined using a standard curve
for each gene target that was generated using genomic DNA isolated from
106,105, 104, 103, 102, and 101 spirochetes. Samples were analyzed in triplicate with at least two biological replicates, and gene expression was reported as the number of gene transcripts per flaB mRNA copy. The am-
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plification of samples lacking reverse transcriptase was similar to that of
the no-template control. Data sets were compared using the nonparametric Kruskal-Wallis test with Dunn’s multiple-comparison test using
GraphPad Prism 5.0 for Windows (GraphPad Software).
Radioactive-transport assays. B. burgdorferi clones were grown in 40
ml of BSK II medium to a density of 8 ⫻ 107 spirochetes/ml, washed twice
with HN buffer (50 mM HEPES, 50 mM NaCl [pH 7.6]), and resuspended
in a final volume of 2.5 ml of HN buffer. Aliquots of 500 l each (⬃5 ⫻ 108
spirochetes) of spirochetes were combined with 20 l of 300 mM glucose
(6 mM final concentration) and an additional 480 l of HN buffer. Spirochetes were preincubated at 37°C for 30 min. A 250 nM concentration
of [3H]hypoxanthine monohydrochloride (specific activity, 20 Ci/mmol)
(PerkinElmer) or 33 nM [2,8-3H]adenine (specific activity, 30 Ci/mmol)
(PerkinElmer) was added to the reaction mixture, and 100-l aliquots of
the reaction mixture (5 ⫻ 107 spirochetes) were removed at various time
points following the addition of radioactivity, filtered onto cellulose acetate filter membranes using a 10-place filtration manifold (Hoefer, Inc.),
and immediately washed with 10 ml of HN buffer. Filter-bound spirochetes were collected in scintillation vials containing 3 ml of ScintiVerse
BD cocktail scintillation fluid (Fisher Scientific) and radioactivity counted
in a Microbeta2 with an efficiency of 52% (PerkinElmer). The rates of
uptake of hypoxanthine and adenine (picomoles/107 spirochetes/minute)
were calculated by first converting counts per minute (cpm) to picomoles
assuming 1 cpm ⫽ disintegrations per minute (dpm) ⫻ an efficiency of
0.52 and 1 Ci ⫽ 2.2 ⫻ 1012 dpm. The rates corresponding to the time
points for the linear portion of each uptake curve were averaged to determine the average rate of uptake.
Spirochetes for [3H]hypoxanthine monohydrochloride uptake assays
in the presence of cold competitors were grown and prepared as described
above. Stock solutions (1 mM) of each cold competitor— hypoxanthine,
adenine, guanine, xanthine, cytosine, thymine, uracil, ascorbic acid, and
5=-deoxy-5=-(methylthio)adenosine (MTA)—were prepared in 8 mM
NaOH. Reactions were initiated with the addition of 50 l of competitor
(50 M final concentration, 200-fold excess) or 50 l of 8 mM NaOH
alone and 250 nM [3H]hypoxanthine monohydrochloride. A 100-l aliquot (5 ⫻ 107 spirochetes) of each reaction mixture was removed 10 min
following the addition of radioactivity, filtered onto cellulose acetate filter
membranes using a 10-place filtration manifold (Hoefer, Inc.), and immediately washed with 10 ml of HN buffer. Filter-bound spirochetes were
collected in scintillation vials containing 3 ml of ScintiVerse BD cocktail
scintillation fluid (Fisher Scientific) and radioactivity counted in a Microbeta2 (PerkinElmer). A3-68⌬BBE02 and A3-68⌬BBE02 heated to 95°C
for 10 min served as the wild-type control and the heat-killed negative
control, respectively, for all transport assays. Each transport assay was
repeated in triplicate.
Mouse infection experiments. The University of Central Florida
(UCF) is accredited by the International Association for Assessment and
Accreditation of Laboratory Animal Care. Protocols for all animal experiments were prepared according to the guidelines of the National Institutes of Health and approved by UCF’s Institutional Animal Care and Use
Committee. For gene expression studies, four mice (C3H/HeN, 6- to
8-week-old females; Harlan) were needle inoculated, 80% intraperitoneally and 20% subcutaneously, with B. burgdorferi clone B31 A3 at a dose of
1 ⫻ 105 spirochetes. For infectivity studies, groups of 6 mice each (C3H/
HeN, 6- to 8-week-old females; Harlan) were needle inoculated, 80%
intraperitoneally and 20% subcutaneously, with clone ⌬bbb22-23/vector
or ⌬bbb22-23/bbb22-23⫹ at a dose of 1 ⫻ 104 or 1 ⫻ 107 spirochetes. The
number of spirochetes inoculated into mice was determined using a
Petroff-Hausser counting chamber and verified by CFU counts in solid
BSK medium. Ten colonies per inoculum were verified by PCR for the
presence of the virulence plasmids lp25, lp28-1, and lp36 in at least 90% of
the individuals in the population. Further, the total plasmid content of
each inoculum was confirmed to be as expected (18). Mouse infection was
assessed 3 weeks postinoculation by serology and reisolation of spirochetes from ear, bladder, and joint tissues, as previously described (18).
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Heart tissues were harvested from B31 A3-inoculated mice for RNA isolation and gene expression studies.

RESULTS

BBB22 and BBB23 open reading frames on cp26. The BBB22 and
BBB23 open reading frames (ORFs) are in the same orientation
and separated by 109 bp (8, 13). The bbb22 and bbb23 genes (1,356
bp and 1,392 bp, respectively) and their annotated proteins (451
amino acids and 463 amino acids, respectively) are 79.8% and
78.3% identical at the nucleotide and amino acid levels, respectively, suggesting that these genes may be paralogs and their encoded proteins may have overlapping functions in B. burgdorferi.
Both BBB22 and BBB23 are annotated as guanine and xanthine
permeases and have a conserved domain, COG2252 (xanthine,
uracil, and vitamin C permease), that is a distant subfamily of the
NCBI CD superfamily cI00967 NAT (nucleobase and ascorbate
transporter) family (23). BBB22 and BBB23, similar to other
COG2252 domain proteins, are predicted to both localize to the
bacterial inner membrane and contain 12 transmembrane domains (9, 20, 21, 40, 42) (Fig. 1). Current annotation of the BBB23
ORF suggests that translation of the BBB23 protein initiates at the
alternative start codon TTG and produces a 463-amino-acid protein that is 12 amino acids longer than the predicted 451-aminoacid size for the BBB22 protein (8, 13) (Fig. 1). Upon further
analysis of the BBB23 ORF sequence, we identified an ATG start
codon 36 nucleotides within the current annotation of the BBB23
ORF, which is preceded by a reasonable Shine-Dalgarno sequence
5 bp upstream. Our prediction of this ATG residue as the putative
true start codon for the BBB23 protein resulted in the additional
prediction that the BBB23 ORF produces a 451-amino-acid protein, as is predicted for BBB22.
The bbb22-23 genes are essential for B. burgdorferi mouse
infectivity. Given the high degree of amino acid identity between
the BBB22 and BBB23 proteins, it is reasonable to predict that
these two proteins could have overlapping functions and that in
the absence of one, the other may be able to functionally compensate. Moreover, we have found that both genes are expressed during mammalian infection (Fig. 2), suggesting that both proteins
may be important for survival in the mouse. Therefore, in order to
examine the combined functional role of the BBB22 and BBB23
proteins during mammalian infection, the sequence encompassing both open reading frames was deleted from low-passage, infectious B. burgdorferi and replaced with the flaBp-aadA spectinomycin and streptomycin resistance cassette (17) by allelic
exchange (Fig. 3). Successful recovery of ⌬bbb22-23 spirochetes
demonstrates that the function of the encoded proteins is not
essential for B. burgdorferi survival in vitro. The ⌬bbb22-23 spirochetes were genetically complemented in trans on the shuttle vector pBSV2G (12) with wild-type copies of the bbb22 and bbb23
genes and102 bp of the 5= upstream sequence encompassing the
presumed promoter of bbb23. In vitro growth analysis demonstrated no difference in growth between ⌬bbb22-23, ⌬bbb22-23/
bbb22-23⫹, and wild-type spirochetes over the course of 96 h (data
not shown), suggesting that the functions of the gene products are
not required for spirochete replication in nutrient-rich BSK II in
vitro growth medium.
The contribution of the bbb22-23 genes to B. burgdorferi mammalian infectivity was assessed by inoculation of mice with mutant
spirochetes lacking bbb22-23 or the isogenic bbb22-23⫹ complemented clone at a dose of 1 ⫻ 104 spirochetes. None of the mice
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FIG 1 The BBB22 and BBB23 proteins demonstrate a high level of identity. Shown is an amino acid sequence alignment of the BBB22 (NP_047008.1) and BBB23
(NP_047009.2) proteins, according to current annotation. Identical amino acids are shaded. Amino acid sequences were aligned using the Clustal W algorithm
in the MegAlign program from the DNASTAR Lasergene suite. The putative sequences of the 12 transmembrane domains were predicted using the TMHMM
server, version 2.0 (http://www.cbs.dtu.dk/services/TMHMM/), and are indicated with gray underlines. Divergent sequences in putative periplasmic loops 4 and
6 are indicated with black underlines. An alternative prediction for the start codon of BBB23 is indicated with a black arrow.

FIG 2 The bbb22 and bbb23 genes are expressed during murine infection.
Spirochete RNA was isolated from log-phase (3 ⫻ 107 spirochetes/ml) B. burgdorferi clone B31 A3 grown in BSK II medium, pH 7.5, at 35°C (in vitro). Total
RNA was isolated from spirochete-infected heart tissue harvested 2 weeks after
intradermal inoculation of C3H/HeN mice with 1 ⫻ 105 B. burgdorferi clone
B31 A3 spirochetes (in vivo). Expression of genes flaB, bbb22, and bbb23 was
quantified by reverse transcriptase qPCR. The data are expressed as the number of bbb22 or bbb23 gene transcripts per number of flaB mRNA copies. The
in vitro data represent the averages of two biological replicates. The in vivo data
represent the averages of four biological replicates. Error bars represent the
standard deviations from the means. All data sets were compared pairwise
using the Kruskal-Wallis nonparametric rank test followed by Dunn’s multiple-comparison test (GraphPad Prism 5.0) and were found to have no statistical difference.
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inoculated with the ⌬bbb22-23 mutant spirochetes became infected, as assessed by serology and reisolation of spirochetes from
tissues 3 weeks postinoculation (Table 2). Conversely, six out of
six mice inoculated with the bbb22-23⫹ complemented clone were
seropositive, and spirochetes were reisolated from tissues (Table
2). To further explore the role of these genes in B. burgdorferi
murine infection, mice were inoculated with 1 ⫻ 107 mutant or
complemented spirochetes. Strikingly, no mice inoculated with
spirochetes lacking bbb22-23 were infected, even at this high dose,
whereas all mice inoculated with the complemented spirochetes
became infected (Table 2). Together, these data demonstrate that
bbb22 and/or bbb23 is absolutely required for B. burgdorferi mouse
infectivity by needle inoculation.
BBB22 and/or BBB23 are hypoxanthine, adenine, and guanine transporters. Transport and incorporation of hypoxanthine
and adenine by wild-type B. burgdorferi have been demonstrated
previously (3, 22, 26). Contrary to the annotated function of
COG2252 domain proteins, none of the biochemically characterized members of this family has been shown to transport xanthine,
uracil, or vitamin C. Instead, they have all been found to function
as purine permeases capable of transporting adenine, hypoxanthine, and/or guanine (5, 6, 9, 33), supporting the hypothesis that
BBB22 and BBB23 are responsible for transport of purines in B.
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FIG 3 Generation of the ⌬bbb22-23 mutant in B. burgdorferi. (A) Schematic

representation of the wild type (WT) and ⌬bbb22-23 loci on cp26. The sequence of the BBB22-23 open reading frame was replaced with a flaBp-aadA
antibiotic resistance cassette. Locations of primers for analysis of the mutant
clones are indicated with small arrows and labels P1 to P6. Primer sequences
are listed in Table 1. The boundaries of the deletion construct are indicated by
broken lines. (B) PCR analysis of mutant clones. Genomic DNA isolated from
WT and ⌬bbb22-23 spirochetes served as the template DNA for PCR analyses.
DNA templates are indicated across the top of the gel image. The oligonucleotide pairs used to amplify specific DNA sequences are indicated below the gel
image and correspond to target sequences as shown in panel A.

burgdorferi. BBB22-23⫹ and BBB22-23⫺ spirochetes were examined for transport of hypoxanthine and adenine using a radioactive filter-binding assay (37). Transport of [3H]hypoxanthine was
found to be dependent on the BBB22 and/or BBB23 protein, as the
⌬bbb22-23 mutant clone, similar to heat-killed wild-type spirochetes, was incapable of hypoxanthine uptake (Fig. 4A). Conversely, wild-type and complemented spirochetes demonstrated
increased accumulation of [3H]hypoxanthine over a period of approximately 15 min (Fig. 4A). Unlike transport of [3H]hypoxanthine, transport of [3H]adenine was not completely BBB22 and/or
BBB23 dependent (Fig. 4B). The ⌬bbb22-23 mutant clone demonstrated transport of [3H]adenine. The average rate of [3H]adenine
uptake for the ⌬bbb22-23 mutant spirochetes (0.015 ⫾ 0.006 pmol/
107 spirochetes/min) was reduced 68-fold relative to that of wild-type
and complemented spirochetes (0.99 ⫾ 0.02 pmol/107 spirochetes/
min). A period of approximately 15 min was required for the mutant
TABLE 2 bbb22 and/or bbb23 is required for B. burgdorferi mouse
infectivity
Spirochete dose
per mouse

No. of infected
mice/totala

⌬bbb22-23/pBSV2G

1 ⫻ 104
1 ⫻ 107

0/6
0/6

⌬bbb22-23/pBSV2G bbb22-23

1 ⫻ 104
1 ⫻ 107

6/6
6/6

Clone

a
Number of infected mice per number of mice analyzed, determined 3 weeks
postinoculation by positive serology against B. burgdorferi proteins and reisolation of
spirochetes from ear, bladder, and joint tissues.
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FIG 4 BBB22 and/or BBB23 are hypoxanthine, adenine, and guanine permeases.
[3H]hypoxanthine uptake (A) and [3H]adenine uptake (B) by wild-type (WT),
heat-killed WT (WT-HK), ⌬bbb22-23 mutant (⌬bbb22-23/vector), and ⌬bbb22-23
complemented (⌬bbb22-23/bbb22-23⫹) spirochetes were measured over a 30min time course. Uptake of radiolabeled purine is expressed in picomoles/107
spirochetes/minute. The final concentrations of labeled hypoxanthine and adenine in the reactions were 250 nM and 33 nM, respectively. The specific
activities of labeled hypoxanthine and adenine were 20 Ci/mmol and 30 Ci/
mmol, respectively. Data shown are representative results of one of three replicate experiments. (C) [3H]hypoxanthine (250 nM, 20 Ci/mmol) uptake by
wild-type spirochetes was measured in the absence (no competitor) or presence of a 200-fold excess (50 M) of unlabeled competitor as indicated. Heatkilled wild-type (heat killed) and ⌬bbb22-23 mutant (⌬bbb22-23) spirochetes
in the absence of competitor served as negative controls. Radioactivity uptake
was measured 10 min after the addition of [3H]hypoxanthine with or without
unlabeled competitor. Radioactivity uptake by wild-type spirochetes in the
absence of competitor was taken as 100%. All other data are represented as the
percent uptake relative to that by wild-type spirochetes in the absence of
competitor. Error bars represent the standard deviations of triplicate experiments. Statistical analyses were performed using the unpaired t test
(GraphPad Prism 5.0).

spirochetes to accumulate a maximum level of [3H]adenine equivalent to that of spirochetes harboring functional BBB22-23 proteins.
Wild-type and complemented spirochetes achieved maximum
[3H]adenine uptake within the first 1 min of the assay (Fig. 4B). The
average rate of [3H]adenine uptake by wild-type and complemented
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spirochetes was 29-fold higher than the average rate of [3H]hypoxanthine uptake by the same two clones (0.035 ⫾ 0.005 pmol/107 spirochetes/min). [3H]adenine transport by wild-type spirochetes was
greater than 80% inhibited in the presence of a 200-fold excess of
unlabeled adenine (data not shown). Together, these data demonstrate that BBB22 and/or BBB23 is responsible for salvage of hypoxanthine; these proteins contribute to uptake of adenine by B. burgdorferi, but the spirochetes appear to harbor additional transport
systems important for this function.
To further elucidate the function of the BBB22-23 transport
system, we took advantage of the finding that BBB22 and/or
BBB23 is the only transporter system for hypoxanthine uptake.
The ability of these proteins to transport other substrates was determined by measuring [3H]hypoxanthine uptake in the presence
of a 200-fold excess of unlabeled competitors, including purine
derivatives, pyrimidines, and ascorbic acid. As expected, unlabeled adenine and hypoxanthine competed for [3H]hypoxanthine
uptake. The percent [3H]hypoxanthine uptake in the presence of
unlabeled adenine or hypoxanthine was not statistically different
from that of heat-killed and ⌬bbb22-23 mutant spirochetes (adenine, P ⫽ 0.1 and P ⫽ 0.95, respectively; hypoxanthine, P ⫽ 0.69
and P ⫽ 0.27, respectively; unpaired t test) (Fig. 4C). Furthermore, these analyses established that guanine is an additional substrate for BBB22 and/or BBB23, as the percent [3H]hypoxanthine
uptake in the presence of excess unlabeled guanine was similar to
that of heat-killed and ⌬bbb22-23 mutant spirochetes (P ⫽ 0.38
and P ⫽ 0.11, respectively; unpaired t test) (Fig. 4C). The presence
of xanthine, cytosine, thymine, uracil, or ascorbic acid had no
inhibitory effect on [3H]hypoxanthine uptake, indicating that
these metabolites are not transported by BBB22 or BBB23 (Fig.
4C). All in all, these data clearly establish BBB22 and/or BBB23
function as a hypoxanthine, adenine, and guanine permease.
5=-Methylthioadenosine (MTA) is a sulfur-containing nucleoside
produced from S-adenosylmethionine (SAM) during polyamine
synthesis in mammalian tissues (1) and polyamine, autoinducer-1,
and biotin synthesis in bacteria (11). Bacterial 5=-methylthioadenosine/S-adenosylhomosysteine (MTA/SAH) nucleosidases (Pfs) catalyze the cleavage of MTA into 5=-methylthioribose (MTR) and adenine (25). Borrelia burgdorferi harbors three pfs homologs, BB0588
(bgp or pfs-2), BB0375 (pfs-1), and BBI06 (mtnN). Bgp and Mtn are
believed to be present on the surface of the spirochete, whereas Pfs-1
is predicted to localize to the cytoplasm (11, 25). Both Bgp and Pfs-1
have demonstrated MTA nucleosidase activity (25), and together
these proteins are predicted to contribute to adenine salvage from
spirochete and host metabolism (11). To test the hypothesis that
MTA may provide a source of adenine for salvage by B. burgdorferi,
MTA was examined for its ability to compete for [3H]hypoxanthine
transport by BBB22-23. In the presence of MTA, [3H]hypoxanthine
transport was significantly reduced relative to transport in the absence of competitor (P ⫽ 0.0006; unpaired t test); however, MTA was
not sufficient to reduce [3H]hypoxanthine transport levels equivalent
to that of heat-killed or ⌬bbb22-23 mutant spirochetes (P ⫽ 0.0012
and P ⫽ 0.0030, respectively; unpaired t test) (Fig. 4C). These data
support the hypothesis that exogenous MTA can serve as a source of
adenine for salvage by B. burgdorferi.
DISCUSSION

During its infectious cycle, B. burgdorferi experiences environments with potentially distinct purine availability. Hypoxanthine
is the most abundant purine in mammalian blood (16), and it is
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presumed to be available for salvage by B. burgdorferi during the
blood meal of an infected tick and during the spirochete’s transient presence in the mammalian bloodstream. During mammalian infection, B. burgdorferi resides in various tissues which have
been shown to be rich in adenine (41). Guanine is present at low
levels in mammalian blood and tissues (16, 41). It has been demonstrated previously that B. burgdorferi is able to transport and
incorporate adenine, hypoxanthine, nucleosides, and deoxynucleosides into DNA and RNA (22, 26). However, little to no
transport of guanine or xanthine has been previously observed for
B. burgdorferi (26). We now establish that the homologous proteins BBB22 and/or BBB23, encoded on cp26, transport hypoxanthine, adenine, and guanine and are necessary for B. burgdorferi
mammalian infection. The bbb22 and/or bbb23 gene product was
found to be essential for hypoxanthine uptake. At least one of
these transporters is also important for adenine uptake; however,
our data revealed that an additional, as-yet-unknown, protein(s)
also contributes to this function. Nonetheless, the function of the
additional adenine transporter(s) was not sufficient to allow full
or even attenuated survival of ⌬bbb22-23 mutant B. burgdorferi in
the mouse, as spirochetes lacking only bbb22-23 were unable to
infect mice up to a dose of 1 ⫻ 107 bacteria. These data suggest that
transport of hypoxanthine, rather than adenine, may be critical
during the initial stages of B. burgdorferi mammalian infectivity,
consistent with the transient dissemination of spirochetes through
the blood early in infection, while adenine salvage may be critical
for persistent survival of B. burgdorferi in tissues. In addition to
direct scavenge of adenine from host tissues, our data suggest that
catabolism of MTA produced by the host may provide a source of
exogenous adenine for purine salvage. B. burgdorferi harbors two
MTA nucleosidase homologs, Bgp and BBI06, which have been
shown and predicted, respectively, to localize to the spirochete’s
outer surface, suggesting that the biological role of these enzymes
is to catabolize host-derived MTA (25). Spirochetes lacking bgp
maintain wild-type virulence in mice (25), indicating that BBI06 is
able to compensate for the loss of Bgp activity or that MTA catabolism contributes little to B. burgdorferi survival in the mammal.
Hypoxanthine transport by BBB22 and/or BBB23 was competitively inhibited by guanine, demonstrating for the first time that B.
burgdorferi is able to transport guanine, and this likely occurs via
BBB22 and/or BBB23. Contrary to annotation of BBB22 and
BBB23 as xanthine, uracil, and vitamin C permeases, none of these
metabolites was able to compete for hypoxanthine transport. Furthermore, BBB22 and BBB23 function did not include pyrimidine
transport, as neither cytosine nor thymine competed for hypoxanthine transport. These data are consistent with the function of the
protein members of a new class of nucleobase transporters containing COG2252 defined by the Aspergillus nidulans hypoxanthine, adenine, and guanine permease, AzgA (9). Additional characterized members of this subfamily include the E. coli adenine
permease, PurP (5, 6), and the two Bacillus subtilis guanine and
hypoxanthine permeases, PbuG and PbuO (31–33).
Despite the critical roles of BBB22 and/or BBB23 in purine
uptake in vivo, spirochetes lacking bbb22-23 do not exhibit a
growth defect in vitro. The rich, complex B. burgdorferi in vitro
growth medium provides excess purines and is likely a source of
nucleosides and deoxynucleosides. In the presence of excess nutrients, the unidentified, additional adenine transporter system
may provide a mechanism for the spirochetes to salvage sufficient
amounts of adenine for survival in the absence of BBB22 and
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BBB23. We have demonstrated previously that adenine is converted to hypoxanthine by the adenine deaminase activity of
BBK17 (AdeC), which may relieve the requirement for hypoxanthine salvage in environments high in adenine (18). B. burgdorferi
has been shown to import and incorporate into DNA and RNA
exogenous nucleosides and deoxynucleosides (22). Direct salvage
of nucleosides and deoxynucleosides by a transport system other
than BBB22 and BBB23 may allow the spirochetes to bypass the
requirement for hypoxanthine, adenine, and/or guanine transport to synthesize DNA and RNA. This mechanism has also been
suggested to explain the absence of an in vitro growth defect for
spirochetes lacking the in vivo essential, purine salvage genes guaA
and guaB (19).
The high degree of sequence identity shared between bbb22
and bbb23 suggests that these two genes have evolved as the result
of a duplication event. Moreover, this prediction raises the question of why B. burgdorferi has two purine permeases encoded by
adjacent, paralogous genes on cp26. One possibility is that the two
proteins have distinct substrate specificities. The BBB22 and
BBB23 proteins are predicted to traverse the spirochete’s inner
membrane, and therefore, the amino acid sequences of the six
periplasmic loops of each protein are likely important determinants of the substrates that are transported by these purine permeases. Two of the six putative periplasmic loops within BBB22
(amino acids 207 to 254 and 418 to 431) and BBB23 (amino acids
219 to 266 and 430 to 443) (Fig. 1) are predicted to be highly
divergent between the two proteins, suggesting that these domains
may contribute to differential substrate specificity between the
two proteins, if any. Alternatively, BBB22 and BBB23 may have
similar substrate specificities but each protein functions in response to distinct environmental cues. The sequences and synteny
of the BBB22 and BBB23 homologs appear to be conserved among
the Lyme disease Borrelia spp. Conversely, the relapsing fever spirochetes appear to only harbor distantly related BBB23-like sequences
(data not shown). Furthermore, the Lyme disease spirochetes lack the
key purine salvage enzymes ribonucleotide reductase, hypoxanthineguanine phosphoribosyltransferase (Hpt), adenylosuccinate synthase (PurA), and adenylosuccinate lyase (PurB) (3, 22, 26), which
are present in the relapsing-fever spirochetes (3, 22, 26), and the presence or absence of BBB22 and BBB23 homologs may reflect the distinct purine salvage requirements between the two groups of pathogens.
The bbb22 and bbb23 transcripts were detected in spirochetes
grown in the in vivo mammalian host environment. Although not
statistically significant, the data suggest that the levels of bbb22 and
bbb23 expression in vivo, as determined by reverse transcriptionquantitative real-time PCR, may be increased relative to the levels
of expression of these genes under nutrient-rich in vitro growth
conditions. Furthermore, these data imply that the expression of
the encoded permeases may be upregulated in response to potentially nutrient-limited growth conditions in which purine salvage
is likely critical for B. burgdorferi survival. Key purine salvage enzymes, IMP dehydrogenase (GuaB) and GMP synthase (GuaA)
for the synthesis of GTP and dGTP, have been shown to be indispensable for B. burgdorferi survival throughout its infectious cycle
(19), suggesting that the tick vector and mammalian host environments are limited for direct scavenge of GTP and dGTP for RNA
and DNA biosynthesis. Moreover, despite evidence presented
herein that guanine can be transported by BBB22 and/or BBB23,
guanine and guanine nucleotide precursors are thought to be lim-
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iting for B. burgdorferi survival in vivo (19, 22). B. burgdorferi has
evolved a unique purine salvage pathway in the absence of the
“classic” purine salvage pathway enzymes (3, 22, 26), in order to
generate dGTP from salvaged hypoxanthine or hypoxanthine derived from deaminated salvaged adenine (18, 19, 22). Based on
these data, it is intriguing to speculate that expression of bbb22
and/or bbb23 may be controlled by the availability of guanine
nucleotide precursors, leading to increased hypoxanthine and/or
adenine transport when guanine nucleotide pools are low. In support of this notion, purine nucleotide metabolism in E. coli and B.
subtilis has been shown to be controlled by the availability of purine nucleotides from the environment (5, 10, 33). The relative
contributions of BBB22 and BBB23 individually to purine salvage
and spirochete survival in vivo, as well as the regulatory mechanism(s) controlling bbb22 and bbb23 expression, are under investigation.
We have demonstrated that BBB22 and BBB23 function in the
critical first step of the purine salvage pathway in B. burgdorferi
and, in turn, are a gateway into the spirochete for the acquisition
of essential nutrients. These transporters may also provide a novel
means to deliver potential antispirochete molecules. Understanding the molecular determinants of substrate specificity and regulation of BBB22 and BBB23 may provide the framework for rational design of inhibitors or antimetabolites targeted against the B.
burgdorferi purine salvage pathway, resulting in new treatments
for Lyme disease.
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